WPRIM Management System> DCMS> Chinese Journal of Urology> > 43> 11

Volume: 43 Issue: 11

1. Renewal and interpretation of concepts related to paragangliomas and pheochromocytomas according to WHO classification in 2022 Page:807—811
2. Clinical application of 68Ga-pentixafor PET/CT in surgical diagnosis and prognosis evaluation of primary aldosteronism and correlation analysis of clinical prognosis Page:812—817
3. Analysis of clinical characteristics of 985 patients with Cushing's syndrome treated with adrenal surgery in a single center Page:818—824
4. The efficacy and safety of posterior retroperitoneoscopic adrenalectomy in the prone position Page:825—829
5. The efficacy and safety comparison of transperitoneal laparoscopic adrenalectomy and retroperitoneal laparoscopic adrenalectomy for adrenocortical carcinoma Page:830—834
6. Robot-assisted laparoscopic partial nephrectomy with renal hypothermia perfusion in complex renal tumor Page:835—839
7. Exploration of the relationship between the urethral pressure profilometry and the complications of artificial urethral sphincter implantation Page:840—844
8. Predictive value of maximum ureteral wall thickness at stone bed position for extracorporeal shock wave lithotripsy in the treatment of ureteral calculi Page:845—849
9. Optimizing the core numbers in MRI-TRUS fusion targeted prostate biopsy Page:850—854
10. The efficacy and safety of prostatic urethral lift for benign prostatic hyperplasia: a systematic review and Meta-analysis Page:855—860
11. Efficacy and safety of black tomato concentrated sauce in the treatment of benign prostatic hyperplasia Page:861—866
12. Multi-directional differentiation renal cell cancer: a case report Page:867—868
13. The nephrostomy tube insertion into the vena cava by mistake: a report of 3 cases Page:869—870
14. Treatment of vesicovaginal fistula after radiotherapy with gracilis flap: one case report Page:871—872
15. Status and prospect of CAR-T cell therapy for prostate cancer Page:877—880
16. Management of cardiovascular health in prostate cancer patients with androgen deprivation therapy Page:873—876